Internal Medicine, Pulmonary Disease · Tampa, FL
NPI
1295994952
Since 2008
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
2 Tampa General Circle, Stc 6th Floor
Tampa, FL, 33606
Phone (813) 259-0619
Groups this clinician bills Medicare through
Medicare paid, 2024
$62K
611 services
Medicare patients, 2024
292
Average age 71
Drug cost, 2024
$23.1M
2,994 prescriptions
Company payments, 2025
$115K
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ricardo Restrepo-Jaramillo was code 99214 (office e&m - established), 143 times for 112 patients. In total Ricardo Restrepo-Jaramillo billed 611 services in 19 codes, and Medicare paid $62K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-03-30.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 143 | 112 | $75.58 | $11K |
| 99215 Office E&M - Established | Facility | 102 | 74 | $110.84 | $11K |
| 99291 Critical Care E&M | Facility | 95 | 38 | $166.38 | $16K |
| 93451 Percutaneous Transcatheterization | Facility | 65 | 62 | $101.52 | $6,599 |
| 99233 Hospital E&M - Subsequent | Facility | 60 | 40 | $92.26 | $5,535 |
| 99232 Hospital E&M - Subsequent | Facility | 45 | 31 | $61.38 | $2,762 |
| 99204 Office E&M - New | Facility | 25 | 25 | $104.55 | $2,614 |
| 99222 Hospital E&M - Initial | Facility | 22 | 22 | $102.18 | $2,248 |
| 99223 Hospital E&M - Initial | Facility | 13 | 13 | $135.14 | $1,757 |
By year: 2022 $65K for 599 services; 2023 $54K for 624 services; 2024 $62K for 611 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ricardo Restrepo-Jaramillo prescribed most often to Medicare patients was Opsumit (Macitentan), with 458 prescriptions and refills. In total Ricardo Restrepo-Jaramillo wrote 2,994 Medicare prescriptions that cost $23.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Opsumit Macitentan | 458 | 458 | 52 | $5.7M |
| Sildenafil Citrate Generic | 425 | 776 | 86 | $72K |
| Adempas Riociguat | 299 | 307 | 37 | $4.2M |
| Tyvaso Dpi Treprostinil | 207 | 207 | 23 | $4.8M |
| Orenitram Er Treprostinil Diolamine | 206 | 206 | 13 | $2.0M |
| Ambrisentan Generic | 167 | 173 | 17 | $415K |
| Uptravi Selexipag | 151 | 151 | 17 | $3.7M |
| Potassium Chloride Generic | 129 | 238 | 33 | $1,293 |
| Furosemide Generic | 125 | 273 | 44 | $544 |
| Tadalafil Generic | 124 | 162 | 22 | $137K |
| Bumetanide Generic | 81 | 133 | 20 | $2,136 |
| Midodrine Hcl Generic | 63 | 128 | 16 | $9,827 |
| Spironolactone Generic | 52 | 126 | 13 | $201 |
| Letairis Ambrisentan | 39 | 39 | Under 11 | $502K |
| Omeprazole Generic | 34 | 75 | Under 11 | $524 |
Brand drugs: 1,630 claims; generic drugs: - claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ricardo Restrepo-Jaramillo $115K ($115K in general payments such as food, travel and fees) from 18 companies. The largest payer was United Therapeutics Corporation with $45K.
| Company | Payments | Amount |
|---|---|---|
| United Therapeutics Corporation UTHR | 67 | $45K |
| Actelion Pharmaceuticals US, Inc. JNJ | 39 | $31K |
| Merck Sharp & Dohme LLC MRK | 24 | $29K |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 4 | $5,144 |
| Chiesi USA, Inc. | 5 | $4,063 |
| Abiomed JNJ | 2 | $267 |
| Innovation Technologies Inc | 1 | $174 |
| Liquidia Technologies, Inc. | 1 | $80.8 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $76.21 |
| Sandoz Inc. SDZ.SW | 3 | $68.81 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.